It Is just a nootropic drug invented in 1996 by a workforce Operating for Merck, Sharp and Dohme, that was the main compound designed which acts being a subtype-selective inverse agonist at the αfive subtype in the benzodiazepine binding web page over the GABAA receptor. Bostic, J Q et al. https://chemicalglobe.com/